Nanomix Corporation (NNMX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2022 | 15.45 Thousand USD | -89.1% |
| 2021 | 141.77 Thousand USD | 134.83% |
| 2020 | 60.37 Thousand USD | 269.74% |
| 2019 | 16.32 Thousand USD | -48.53% |
| 2018 | 31.72 Thousand USD | 8.06% |
| 2017 | 29.35 Thousand USD | -70.31% |
| 2016 | 98.87 Thousand USD | -0.06% |
| 2015 | 98.94 Thousand USD | 0.0% |
| 2011 | 4112.00 USD | 860.75% |
| 2010 | 428.00 USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2022 Q3 | - USD | -100.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 FY | 15.45 Thousand USD | -89.1% |
| 2022 Q1 | - USD | 100.0% |
| 2022 Q2 | 15.45 Thousand USD | 0.0% |
| 2021 FY | 141.77 Thousand USD | 134.83% |
| 2021 Q2 | - USD | -100.0% |
| 2021 Q1 | 141.77 Thousand USD | 132.19% |
| 2021 Q3 | - USD | 0.0% |
| 2021 Q4 | -141.77 Thousand USD | 0.0% |
| 2020 Q1 | 179.49 Thousand USD | 0.0% |
| 2020 FY | 60.37 Thousand USD | 269.74% |
| 2020 Q2 | -335.85 Thousand USD | -287.11% |
| 2020 Q3 | 141.77 Thousand USD | 142.21% |
| 2020 Q4 | -440.39 Thousand USD | -410.63% |
| 2019 Q3 | 3658.00 USD | -31.89% |
| 2019 FY | 16.32 Thousand USD | -48.53% |
| 2019 Q2 | 5371.00 USD | 31.48% |
| 2019 Q1 | 4085.00 USD | 0.0% |
| 2018 Q3 | 7790.00 USD | -4.6% |
| 2018 FY | 31.72 Thousand USD | 8.06% |
| 2018 Q2 | 8166.00 USD | -11.59% |
| 2018 Q1 | 9236.00 USD | 0.0% |
| 2017 FY | 29.35 Thousand USD | -70.31% |
| 2017 Q1 | 4479.00 USD | 0.0% |
| 2017 Q2 | 5213.00 USD | 16.39% |
| 2017 Q3 | 4400.00 USD | -15.6% |
| 2016 FY | 98.87 Thousand USD | -0.06% |
| 2016 Q2 | 16.28 Thousand USD | 32.29% |
| 2016 Q3 | 11.69 Thousand USD | -28.17% |
| 2016 Q1 | 12.3 Thousand USD | 0.0% |
| 2015 Q2 | 38.85 Thousand USD | -24.31% |
| 2015 Q3 | 4602.00 USD | -88.15% |
| 2015 Q1 | 51.32 Thousand USD | 0.0% |
| 2015 FY | 98.94 Thousand USD | 0.0% |
| 2014 Q2 | 21.39 Thousand USD | -51.19% |
| 2014 Q1 | 43.82 Thousand USD | 0.0% |
| 2014 Q3 | 121.49 Thousand USD | 467.96% |
| 2013 Q1 | 23.33 Thousand USD | 0.0% |
| 2013 Q3 | 217.52 Thousand USD | 10170.07% |
| 2013 Q2 | 2118.00 USD | -90.92% |
| 2012 Q3 | 2520.00 USD | 6.06% |
| 2012 Q2 | 2376.00 USD | -87.4% |
| 2012 Q1 | 18.85 Thousand USD | 0.0% |
| 2011 Q3 | 724.00 USD | -59.03% |
| 2011 Q2 | 1767.00 USD | 268.13% |
| 2011 Q1 | 480.00 USD | 0.0% |
| 2011 FY | 4112.00 USD | 860.75% |
| 2010 FY | 428.00 USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 714.7 Thousand USD | 97.838% |
| IR-Med Inc. | - USD | -Infinity% |
| Polarean Imaging plc | 890.93 Thousand USD | 98.266% |
| Medical Supply International USA, Inc. | 2.81 Million USD | 99.452% |
| Avitar, Inc. | 3.1 Million USD | 99.503% |
| AVITA Medical, Inc. | 50.56 Million USD | 99.969% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | 99.998% |
| Zecotek Photonics Inc. | 86.61 Thousand USD | 82.161% |
| QHSLab, Inc. | 1.4 Million USD | 98.903% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | 99.998% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 52.61 Million USD | 99.971% |
| Escalon Medical Corp. | 11.98 Million USD | 99.871% |
| Aurora Spine Corporation | 14.52 Million USD | 99.894% |
| BrainsWay Ltd. | 31.78 Million USD | 99.951% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 257.39 Thousand USD | 93.998% |
| Hamilton Thorne Ltd. | 68.45 Million USD | 99.977% |
| Vivos Inc. | 19.5 Thousand USD | 20.769% |
| MicroPort Scientific Corporation | 950.72 Million USD | 99.998% |
| Kelyniam Global, Inc. | 2.67 Million USD | 99.422% |
| REMSleep Holdings, Inc. | 203.71 Thousand USD | 92.416% |
| CYduct Diagnostics, Inc. | 84.48 Thousand USD | 81.713% |
| Theraclion SA | 1.82 Million USD | 99.152% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 661.55 Thousand USD | 97.665% |
| Positron Corporation | 734.66 Thousand USD | 97.897% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.34 Million USD | 98.855% |
| Lombard Medical, Inc. | 12.16 Million USD | 99.873% |
| ALR Technologies Inc. | 7468.00 USD | -106.883% |
| Stratec SE | 289.14 Million USD | 99.995% |
| Vycor Medical, Inc. | 1.46 Million USD | 98.942% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 403.53 Thousand USD | 96.171% |
| SANUWAVE Health, Inc. | 20.39 Million USD | 99.924% |
| VMS Rehab Systems, Inc. | 71.70 USD | -21448.117% |
| Guided Therapeutics, Inc. | 98 Thousand USD | 84.235% |
| Ingen Technologies, Inc. | 720.67 Thousand USD | 97.856% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 2.84 Million USD | 99.457% |
| Urologix, Inc. | 14.23 Million USD | 99.891% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | 3.3 Million USD | 99.532% |
| SS Innovations International, Inc. | 5.87 Million USD | 99.737% |
| Qualis Innovations, Inc. | 40.17 Thousand USD | 61.543% |
| Smith & Nephew plc | 5.68 Billion USD | 100.0% |
| NIOX Group Plc | 46.84 Million USD | 99.967% |
| Fuse Medical, Inc. | 16.11 Million USD | 99.904% |
| Broncus Holding Corporation | 10.25 Million USD | 99.849% |
| Brain Scientific Inc. | 214.56 Thousand USD | 92.799% |
| Pressure BioSciences, Inc. | 1.97 Million USD | 99.219% |
| Health Logic Interactive Inc. | - USD | -Infinity% |